Menu ×

The Measles, Mumps and Rubella (MMR) Vaccines Market to Witness Growth on Account of High Incidences of Pneumococcal Infections

  • Text Size:

According to the Center for Disease Control and Prevention (CDC), two doses of MMR are 97% effective against measles and 88% effective against mumps.

According to a recently published report by Research Nester on Measles, Mumps and Rubella (MMR) Vaccines Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the global MMR vaccine market in terms of market segmentation by product type, by end users and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Measles, mumps and rubella are three common contagious airborne diseases that are caused by virus, transmitted by sneezing and coughing of an infected person, which can arise to serious complications or death. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilized formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as combinational vaccines. Combinational MMR vaccines comprises mixture of two or more viral strains. These vaccines are administered by subcutaneous injection to children as well as adults. It is mostly administered to children aged 1 year and second dosage can be administered as early as one month after the first dosage.

The major segments for MMR vaccinations include vaccine manufacturers, vaccine research institutions, clinical laboratories, healthcare centers, vaccine product distributors, bulk purchasing organizations, vaccine raw material suppliers, immunization centers, hospitals and laboratories, biotechnology and pharmaceutical firms.

The WHO reported a 300% increase in measles cases in the first three months of 2019 compared with the same time last year. An estimated 7 million people were affected by the measles in 2016.

Based on regional analysis, the MMR vaccine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North America region is the largest consumer, growth in this region is primarily driven by government initiatives for immunization against diseases such as influenza and HPV. Asia Pacific is expected to expand at a high CAGR driven by government mandates and free immunization programmes against measles. Latin America and Middle East & Africa are expected to show significant growth driven by low cost of vaccinations. The cost of measles vaccinations is less than USD 1 in these regions.

Alliances in order to Improve Vaccination Programs

Vaccine manufacturers are focusing on partnering with organizations such as WHO, UNICEF and GAVI Alliance to improve their vaccination programs, in order to reach the maximum population to offer vaccines. In spite of several governmental initiatives, measles is leading cause of death among young children. Thus, increase in success rate of vaccination schemes depends on government initiatives of each country.

Rising Air Pollution - Rising air pollution levels due to increasing industrialization is leading to propel the airborne diseases globally such as measles which is a significant airborne disease. Initial symptoms related to this disease include fever, cough, redness in the eyes and running nose coupled with rashes in the body.

This report also provides the existing competitive scenario of some of the key players of the MMR vaccine market which includes company profiling of CSL Limited, Emergent BioSolutions, Inc., GlaxoSmithKline Plc., Johnson & Johnson Pvt. Ltd., Pfizer, Sanofi Pasteur, Novartis International AG, Bavarian Nordic A/S, JC Medical, MedImmune, LLC, Merck & Co. Inc. and China National Biotec Group Comp. Ltd.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the measles, mumps and rubella vaccine market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future. 

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved